Evidence map›Paper›PMID 31496753›Full record

ArticleInfection and drug resistance2019

Prevalence of

Sahar Mohammed Khairat, Amal Mohammed Sayed, Mohammad Nabih, Noha Salah Soliman, Yosra Mohammed Hassan

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Research advances on invasive fungal infections after burns].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023
    Review
  10. Characterization of Virulence Factors inJournal of fungi (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Repurposing pantoprazole and haloperidol as efflux pump inhibitors in azole resistant clinicalSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sahar Mohammed KhairatDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
Amal Mohammed SayedDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
Mohammad NabihDepartment of Pediatrics, Faculty of Medicine, Cairo University, Giza, Egypt.
Noha Salah SolimanDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
Yosra Mohammed HassanDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Cairo University, Giza, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOf all blood stream infections (BSI), candidaemia poses the greatest threat with a high fatality rate among children. There has been an increase in the number of reports of non-

aimThe present study aimed to demonstrate the prevalence of candidaemia among children and to characterize the involved species and their susceptibility to antifungal agents. METHODOLOGY: Microbes were isolated from blood samples and identified via standard microbiological procedures. Chromogenic media was used to characterize the STATISTICAL

methodsThe data were analysed with Statistical Package for the Social Science SPSS; SPSS Inc., Chicago, IL, USA) version 15 for Microsoft Windows. Comparisons between the study groups were performed using the Chi square (χ

resultsCandidaemia accounted for 17.3% of all BSIs.

conclusionThe prevalence of candidaemia was high, the fatality rate was alarming and non-

Indexed as

antifungalcandidaemiachromogenic agar

Identifiers

PMID31496753
PMCPMC6689130
OpenAlexW2964497754

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.